These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Use of botulinum toxin in ophthalmology: current concepts and problems]. Tapiero B; Robert PY; Adenis JP; Riss I J Fr Ophtalmol; 1997; 20(2):134-45. PubMed ID: 9099272 [No Abstract] [Full Text] [Related]
7. [Blepharospasm: treatment with botulinum toxin]. Barbosa ER; Silva HC; Haddad MS; Bittar MS Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for the treatment of upper gastrointestinal diseases: the future or already the past? Madaliński MH Endoscopy; 2003 Apr; 35(4):366-7; author reply 368-9. PubMed ID: 12664398 [No Abstract] [Full Text] [Related]
9. [The use of botulinum toxin in otorhinolaryngology--experiences and outlook]. Laskawi R Laryngorhinootologie; 1997 Nov; 76(11):656-9. PubMed ID: 9517972 [No Abstract] [Full Text] [Related]
10. Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening. Forget R; Tozlovanu V; Iancu A; Boghen D Neurology; 2002 Jun; 58(12):1843-6. PubMed ID: 12084888 [TBL] [Abstract][Full Text] [Related]
15. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A. Guntinas-Lichius O Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439 [No Abstract] [Full Text] [Related]
16. [Botulinum toxin: clinical uses and anesthetic implications]. Vidal-Marcos A; Sanz-García M; Infante-Crespo B; Ruiz-Castro M; Rustarazo-Pérez MT; Palma-Gámiz MA Rev Esp Anestesiol Reanim; 1996; 43(6):208-11. PubMed ID: 8756235 [TBL] [Abstract][Full Text] [Related]
18. Dystonic frowning without blepharospasm. Hirota N; Hirota M; Mezaki T Parkinsonism Relat Disord; 2008 Nov; 14(7):579-80. PubMed ID: 18316230 [TBL] [Abstract][Full Text] [Related]
19. [A survey about the accessibility to botulinum toxin therapy for dystonia]. Mezaki T; Hayashi A; Nakase H; Hasegawa K No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]